QualityStocksNewsBreaks Archives - Page 287 of 1504

MondayNov 20, 2023 2:56 pm

QualityStocksNewsBreaks — SenesTech Inc. (NASDAQ: SNES) Announces Expanded Distribution with DIY Pest Control Partner, Exclusive Fertility Control Product

SenesTech (NASDAQ: SNES), the leader in fertility control to manage animal pest populations, has renewed and expanded its distribution with DIY Pest Control. The expansion includes a stocking order for Evolve(TM) Soft Bait, the first and only soft bait product featuring breakthrough, next-generation technology that targets rodent populations by using nonlethal methods to restrict fertility. A leading online distributor of pest control, DIY Pest Control is a family-owned business that services and supplies pest-control companies and consumers. According to the announcement, SNES’s Evolve targets a rat’s ability to rapidly reproduce, effectively reducing fertility in rodents in numerous independent studies. “We…

MondayNov 20, 2023 2:11 pm

QualityStocksNewsBreaks – PaxMedica Inc. (NASDAQ: PXMD) Announces Pricing of $7M Public Offering

PaxMedica (NASDAQ: PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, today announced the pricing of its public offering of an aggregate of 5,384,615 shares of its common stock (or common stock equivalents in lieu thereof) and warrants to purchase up to 5,384,615 shares of common stock, at a combined public offering price of $1.30 per share (or common stock equivalent in lieu thereof) and accompanying warrant. According to the announcement, the warrants will be exercisable immediately upon issuance, at an exercise price of $1.30 per share, and will expire five years after the initial exercise date. Subject…

FridayNov 17, 2023 2:27 pm

QualityStocksNewsBreaks – Eloro Resources Ltd. (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM) Expands on Iska Iska’s Potential

Eloro Resources (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM), an exploration and mining company, recently filed its NI43-101 technical report for its Iska Iska Polymetallic Property in support of its initial mineral resource estimate (“MRE”) published earlier. The company opted to employ the net smelter return (“NSR”) method to encompass the estimated dollar value that each metal contributes towards the total value of each tonne. “Initial findings have estimated an NSR for Iska Iska’s polymetallic domain (containing zinc, tin and silver) of $20.32/t for open pit mining and $42.23/t for underground mining versus NSR cut-off values (representing the cost of extraction…

FridayNov 17, 2023 2:01 pm

QualityStocksNewsBreaks – Ucore Rare Metals Inc.’s (TSX.V: UCU) (OTCQX: UURAF) Proprietary RapidSX(TM) Expected to Improve Standard CSX Solvent Refining Process

Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF) is positioning its proprietary RapidSX(TM) solvent extraction solution to overcome the obstacles in refining metals vital to modern, greener technology. “RapidSX(TM) is expected to match and improve on the standard CSX solvent refining process used by China in its market-dominating extraction of rare earth elements (‘REEs’) from mined product to prepare them for use in high-grade magnets that convert power into motion for modern technologies that range from smartphones to electric vehicles and F-35 fighter jets. Ucore has been proving RapidSX(TM) against the standard CSX process at a demonstration plant in Ontario and…

FridayNov 17, 2023 1:32 pm

QualityStocksNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) Eyes Opportunity in Largely Untapped Precision Medicine Market

Renovaro BioSciences (NASDAQ: RENB), an advanced, preclinical biotechnology company, and GEDi Cube Intl Ltd., an AI medical technology company, previously announced a definitive agreement to combine. The move brings together two innovative platforms in AI and biotherapeutics to offer comprehensive solutions spanning early detection, diagnostic insights and targeted immunotherapies. “According to CEO Dr. Mark Dybul, MD, the AI division intends to launch commercial products for early cancer detection and improved therapy selection in 2024 – rapidly expanding the precision medicine market, which Renovaro is positioned to capture a substantial share of the largely untapped market. The immunotherapy division plans to…

FridayNov 17, 2023 1:08 pm

QualityStocksNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) Releases Update on Federal Lawsuit Filed Against Research Firm

FingerMotion (NASDAQ: FNGR), a mobile services and data company, is reporting an update on the federal lawsuit it filed against Capybara Research last month; the lawsuit alleges that Capybara maliciously published a defamatory article in a premediated attempt to move the public market for FingerMotion's stock lower to benefit from its previously announced short position. According to the update, the company and its litigation counsel, with cooperation from third parties, has spent weeks of work investigating the allegations. As a result, the person responsible for the malicious article has been identified, and the company is taking steps to add that…

FridayNov 17, 2023 10:15 am

QualityStocksNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) News of FDA Type-B Meeting Shared in Syndicated Audio Broadcast

PaxMedica (NASDAQ: PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, is spotlighted in a recent NetworkNewsAudio broadcast. According to the broadcast, the company recently announced that it had met with the U.S. Food and Drug Administration (“FDA”) in a Type-B meeting, designed to discuss the positive results from the company’s PAX-HAT-301 study of suramin in stage one human African sleeping sickness caused by Trypanosoma brucei rhodesiense, a rare and fatal parasitic disease. The broadcast was released by via NetworkNewsAudio (“NNA”), a solution that offer companies additional visibility, recognition and brand awareness in the investment community via distribution…

ThursdayNov 16, 2023 1:41 pm

QualityStocksNewsBreaks – Appia Rare Earths & Uranium Corp. (CSE: API) (OTCQX: APAAF) (FSE: A0I0) Revisits Potential of Elliot Lake Deposits and Bulk Mining Two Zones

Appia (CSE: API) (OTCQX: APAAF) (FSE: A0I0) today announced that it is reevaluating its large uranium-rare earths deposits located at Elliot Lake, Ontario, to examine the impact of increased uranium prices and confirmation of significant rare element (“REE”) mineralization. According to the announcement, the company will also evaluate the cost-saving potential of bulk mining the Teasdale Lake and Banana Lake Zones. In 2007-08 and 2012, Appia completed drill programs to confirm mineralization detailed in historical resource estimates for these zones, after which it engaged consulting firm Watts, Griffis and McOuat Limited (“WGM”) to provide an updated NI 43-101 Resource Estimate.…

ThursdayNov 16, 2023 1:27 pm

QualityStocksNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Partner Receives Key Retail License, Begins Shipping EVs

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, announced that its partner, the Randy Marion Automotive Group (“RMA”), has received its North Carolina license to retail Mullen’s commercial EVs. According to the announcement, this is a required dealer license that allows the auto group to move vehicles to customers. According to RMA officials, the organization is seeing “tremendous interest” in Mullen’s Class 1 and Class 3 vehicles. The new dealer license allows the company to immediately begin delivering Mullen EVs. Beginning Nov. 20, 2023, the company will begin shipping Class 3 vehicles to Adventure Coast Rentals in Tennessee…

ThursdayNov 16, 2023 1:07 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Release Interim Data by Year End for Lead Treatment Candidate Berubicin

CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical company focused on developing innovative therapies for central nervous system disorders, specifically aggressive brain cancers. The company today announced its confidence in sharing the results from an interim analysis on one of its lead treatment candidates, Berubicin, with the public before the end of the year. Berubicin is a chemotherapy drug that interferes with the DNA of cancer cells to inhibit their growth and potentially shrink tumors. Distinct from other anthracyclines, a clinically trusted class of drugs in use for 60 years against dozens of common cancers, and other traditional chemotherapy drugs, CNS…

Site Search

Company Search

Category: QualityStocksNewsBreaks